Cancer Treatment Costs Already Hundreds of Thousands Could Rise Further Affordable Care Act Lessons from a Survivor Deere Company Reports Fiscal Second Quarter 2026 Results Taiwan Chip Stocks Rally as Nvidias 150 Billion Spending Plan Signals Sustained AI Demand Mortgage Rate Snapshot May 27 2026 CBS News Report UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Embecta EMBC Faces Target Price Reduction Amid Weakening Medtech Sector Sentiment TTD Q1 2026 Earnings EPS Misses Estimates But Stock Climbs on Strong Operational Momentum Urban One Inc UONE Q1 2026 Earnings A Deep Loss but Stock Rallies Signaling Resilience EA Q1 2026 Earnings EPS Falls 36 Short of Expectations Victorias Secret Co VSCO Q1 2026 Earnings Earnings Beat Estimates as Company Reports Strong Profitability Defi Technologies Inc DEFT Q4 2025 Earnings EPS Surges Past Estimates by 51 Yet Shares Dip Norfolk Southern Q1 2026 Earnings EPS Beat Lifts Shares Despite Macro Headwinds Muzero Acquisition Corp Unit MUZEU Holds Steady at 1003 Amid Low Volatility iShares Staked Ethereum Trust ETHB Slides 363 as Crypto Weakness Persists Key Support in Focus Saratoga Investment Corp 850 Notes SAZ Edge Lower Amid Modest Selling Pressure FMX Stock Holds Steady Near 121 as Support and Resistance Levels Define Trading Range Mexico Fund Inc MXF Edges Higher Amid Cautious Trading Technical Levels in Focus Trump Targets Republican Opponents Over 18 Billion AntiWeaponisation Fund US Productivity Growth Slows in Q4 as Labor Costs Rise Stifel Upgrades Outlook on Marvell Technology with Increased Price Target Sun Pharma Reports 26 Rise in FourthQuarter Net Profit Driven by Strong Sales and Strategic Investments Southeast Asias Shift Toward Biofuel Crops Tightens Food Supply and Export Capacity Salesforce Shares Decline on Disappointing Revenue Outlook Amid AI Disruption Concerns Flywire CEO Details Efficiency Improvements and AI Integration in Specialty Payment Markets Barings BDC Inc BBDC Q1 2026 Earnings Net Investment Income Misses Estimates as Portfolio Holds Steady Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious